Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design

Summary

The study is designed to assess if spinal cord injury patients have reduced pain after taking either pregabalin or placebo in a cross over design. Patients had either pain at the level of their injury or below the level of their injury.

Timeline

Start

2007-02

Primary completion

2008-10

Completion

2008-10

Outcome

Met primary endpoint

Stopped: “See Detailed Description”

registry analysis (unspecified test); Pregabalin vs Placebo; p = 0.0396; Mean Difference (Final Values) -1.55 (95% CI -3.02 to -0.08); ANOVA NCT00978341 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	150 mg	—

Indications